Showing results (91-100 of 150) with videos related to

Sort By:
Pageof 15
Plos One|July 7, 2023
Integration of point-of-care screening for type 2 diabetes mellitus and hypertension with COVID-19 rapid antigen screening in Johannesburg, South AfricaAlana T Brennan, Beatrice Vetter, Mohammed Majam, et al.
The Lancet. HIV|May 30, 2024
Critical illness due to infection in people living with HIVGuy A Richards, Jarrod Zamparini, Ismail Kalla, et al.
AIDS (London, England)|December 27, 2019
Time to rethink endpoints for new clinical trials of antiretrovirals? Long-term re-suppression of HIV RNA with integrase inhibitorsToby Pepperrell, Willem Daniel Francois Venter, Michelle Moorhouse, et al.
Southern African Journal of HIV Medicine|May 3, 2021
Erratum: Unexpected low frequency of respiratory symptoms in an HIV-positive urban sub-Saharan population compared to an HIV-negative control groupMaren Kummerow, Erica J Shaddock, Kerstin Klipstein-Grobusch, et al.
AIDS (London, England)|June 29, 2026
Clinical implications of the new definition of obesity among persons with HIVAllie R Walpert, Teressa S Thomas, Eva Sanchez, et al.
BMJ Open|May 31, 2017
Simplified clinical algorithm for identifying patients eligible for immediate initiation of antiretroviral therapy for HIV (SLATE): protocol for a randomised evaluationSydney Rosen, Matthew P Fox, Bruce A Larson, et al.
Frontiers in Immunology|July 22, 2021
Patterns of Immune Activation in HIV and Non HIV Subjects and Its Relation to Cardiovascular Disease RiskAlinda G Vos, Caitlin N Dodd, Eveline M Delemarre, et al.
British Journal of Clinical Pharmacology|December 26, 2021
Concentration-response relationships of dolutegravir and efavirenz with weight change after starting antiretroviral therapyRulan Griesel, Aida N Kawuma, Roeland Wasmann, et al.
Mediators of Inflammation|January 10, 2019
Effects of Tobacco Usage and Antiretroviral Therapy on Biomarkers of Systemic Immune Activation in HIV-Infected ParticipantsHelen C Steel, W D Francois Venter, Annette J Theron, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 16, 2021
Participants on Dolutegravir Resuppress Human Immunodeficiency Virus RNA After Virologic Failure: Updated Data from the ADVANCE TrialToby Pepperrell, Willem Daniel Francois Venter, Kaitlyn McCann, et al.
Pageof 15